Takeda Pharmaceutical
280 hedge funds and large institutions have $799M invested in Takeda Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 88 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
280
Holders Change
-5
Holders Change %
-1.75%
% of All Funds
4.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
40
Increased
87
Reduced
88
Closed
39
Calls
$39.1M
Puts
$4.76M
Net Calls
+$34.4M
Net Calls Change
+$3.99M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$59.6M |
| 2 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
$24.4M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
$14.5M |
| 4 |
VanEck Associates
New York
|
$27.9M |
| 5 |
Renaissance Technologies
New York
|
$39.7M |
Top Sellers
| 1 |
Bank of America
Charlotte,
North Carolina
|
$11.9M |
| 2 |
BlackRock
New York
|
$30.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$11.1M |
| 4 |
Goldman Sachs
New York
|
$51M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
$26M |
